PENN AVENUE PARTNERS

Lobbying for FRESENIUS MEDICAL CARE NORTH AMERICA · Provider of kidney dialysis services and renal care products.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 12, 2026

Lobbying activity 1

Health Issues

Policy issues related to end state renal disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.